NCT02856880

Brief Summary

The aim of this exploratory study is to assess the ability of two test toothpastes containing 0.6% w/w zinc chloride stabilised with sodium citrate in a sodium lauryl sulfate (SLS)-containing base to reduce glycolytic metabolism and viability of de novo plaque bacteria using the plaque glycolysis regrowth model (PGRM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2015

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 5, 2016

Completed
7 months until next milestone

Results Posted

Study results publicly available

March 3, 2017

Completed
Last Updated

August 30, 2017

Status Verified

July 1, 2017

Enrollment Period

22 days

First QC Date

June 6, 2016

Results QC Date

August 8, 2016

Last Update Submit

July 31, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area Under the Curve for Glycolysis (AUCgly(0-90)) of Test Zinc-IPMP and Non-SLS Negative Control

    AUCgly(0-90) of Test zinc-IPMP and non-SLS negative control was calculated using trapezoidal method.

    Baseline up to 90 minutes (min)

Secondary Outcomes (3)

  • AUCgly(0-90) for Test Zinc-IPMP, Test Zinc Non-IPMP, Positive Control, Non-SLS Negative Control and SLS Negative Control

    Baseline up to 90 min

  • AUCregrowth(0-90) for Test Zinc-IPMP, Test Zinc Non-IPMP, Positive Control, Non-SLS Negative Control and SLS Negative Control

    Baseline up to 90 min

  • AUClive:Dead(0-90) for Test Zinc-IPMP, Test Zinc Non-IPMP, Positive Control, Non-SLS Negative Control and SLS Negative Control

    Baseline up to 90 min

Study Arms (5)

Test zinc-IPMP toothpaste

EXPERIMENTAL

Rinse with preprepared slurry of toothpaste in 10 milliliter (mL) water for 60 seconds(s) followed by rinse with 10mL water

Other: Test zinc-IPMP toothpaste

Test zinc non- IPMP toothpaste

EXPERIMENTAL

Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water

Other: Test zinc non- IPMP toothpaste

Positive control Toothpaste

ACTIVE COMPARATOR

Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water

Other: Positive control

SLS Negative Control

ACTIVE COMPARATOR

Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water

Other: SLS negative control

non-SLS negative control

ACTIVE COMPARATOR

Rinse with preprepared slurry of toothpaste in 10 mL water for 60s followed by rinse with 10mL water

Other: non-SLS negative control

Interventions

Test toothpaste containing 0.6% w/w zinc chloride and 0.1% w/w IPMP and 1426ppm fluoride as sodium fluoride.

Test zinc-IPMP toothpaste

Test toothpaste containing 0.6% w/w zinc chloride, 0% w/w IPMP and 1426ppm fluoride as sodium fluoride.

Test zinc non- IPMP toothpaste

Positive control toothpaste containing 0.454% w/w stannous fluoride (Fluoride Toothpaste (1100ppm Fluoride as stannous fluoride)).

Positive control Toothpaste

Negative control toothpaste containing 2.0% SLS, 0.65% Tegobetain and 1150 ppm fluoride as sodium fluoride

SLS Negative Control

Negative control toothpaste containing 1426 ppm fluoride as sodium fluoride

non-SLS negative control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • Good general and mental health with, in the opinion of the investigator or medically qualified designee no clinically significant and relevant abnormalities in medical history or upon oral examination.
  • Plaque sample acidogenicity in the pH range 5.0 to 5.7 at Visit.

You may not qualify if:

  • Women who are known to be pregnant or who are intending to become pregnant over the duration of the study.
  • Women who are breast-feeding.
  • Currently taking antibiotics or have taken antibiotics within 2 weeks of plaque assessment (Visit 2). A participant with any medical history that may prevent them from participating in the study until study conclusion (such as diabetes).
  • Any sign of grossly carious lesions (active), moderate or severe periodontal conditions, or severe tooth wear.
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
  • Current smokers, or smokers who have quit within 6 months of screening, or participants currently using smokeless forms of tobacco, e.g. Gutkha, Pan containing tobacco, Pan Masala.
  • Current active caries or periodontitis that may compromise, in the opinion of the investigator, study outcomes or the health of the subject.
  • Restorations in a poor state of repair that may, in the opinion of the investigator, compromise study outcomes or the health of the participant.
  • Partial dentures or orthodontic appliances that may, in the opinion of the investigator, compromise study outcomes or the health of the participant.
  • Recent history (within the last year) of alcohol or other substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GSK Investigational Site

Manchester, M16 9HQ, United Kingdom

Location

MeSH Terms

Conditions

Dental Plaque

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic Diseases

Results Point of Contact

Title
GSK Response Center
Organization
GlaxoSmithKline

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2016

First Posted

August 5, 2016

Study Start

November 9, 2015

Primary Completion

December 1, 2015

Study Completion

December 11, 2015

Last Updated

August 30, 2017

Results First Posted

March 3, 2017

Record last verified: 2017-07

Locations